-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
Clinical efficacy and safety of moroctocog alfa
Emanuela Marchesini, Domenico Prisco, Alfonso Iorio
Review Article: Clinical Investigation
-
Clinical efficacy and safety of moroctocog alfa
Emanuela Marchesini, Domenico Prisco, Alfonso Iorio
Review Article: Clinical Investigation
-
Clinical efficacy and safety of moroctocog alfa
Emanuela Marchesini, Domenico Prisco, Alfonso Iorio
Review Article: Clinical Investigation
-
Clinical efficacy and safety of moroctocog alfa
Emanuela Marchesini, Domenico Prisco, Alfonso Iorio
Review Article: Clinical Investigation
-
Clinical efficacy and safety of moroctocog alfa
Emanuela Marchesini, Domenico Prisco, Alfonso Iorio
Review Article: Clinical Investigation
-
Clinical efficacy and safety of moroctocog alfa
Emanuela Marchesini, Domenico Prisco, Alfonso Iorio
Review Article: Clinical Investigation
-
Clinical efficacy and safety of moroctocog alfa
Emanuela Marchesini, Domenico Prisco, Alfonso Iorio
Review Article: Clinical Investigation
-
Clinical efficacy and safety of moroctocog alfa
Emanuela Marchesini, Domenico Prisco, Alfonso Iorio
Review Article: Clinical Investigation